Patients characteristics according to treatment groupa

All Patients (n = 60)No MOB (n = 43)MOB (n = 17)P Value
Age (yr)72 (±11)72.1 (±10.8)71.9 (±11.2).960
Female (%)57.151.273.3.142
Smoking (%)14.915.613.3.839
Hypertension (%)66.771.453.8.256
Diabetes (%)18.419.415.4.748
Atrial fibrillation (%)6058.364.3.703
Admission glycemia (mg/dL)128.1 ± 38.4125.4 ± 39.3135.9 ± 36.3.465
Systolic blood pressure (mm Hg)143.5 ± 27.5146.7 ± 29134.4 ± 21.2.205
Diastolic blood pressure (mm Hg)76.5 ± 15.479 ± 15.769.4 ± 12.4.076
Occluded vessel: MCA/terminal ICA63.3/36.762.8/37.264.7/35.3.823
Baseline NIHSS20 (18–21)19 (17–21)21 (18–21).089
IV-tPA (%)5558.143.8.328
Time to IV-tPA (min)114 ± 47.6119 ± 52.398 ± 20.9.313
Time to groin193 ± 77193 ± 74192 ± 73.653
IA-tPA (%)67.355.394.1.005
IA-tPA dose10.6 (10.6)16 (9.5)16.8 (4.7).254
Merci retriever use6.64.311.7.35
Recanalization73.267.587.5.06
Time from symptom to recanalization328 (144)316 (177)350 (49).066
Time from groin to recanalization125 (60)118 (66)138 (47).310
NIHSS at 12 hr18 (6.5–20)18 (7–20)17.5 (6–19.2).79
NIHSS at 24 hr16 (3–20)17 (2.5–20)13.5 (3–18.5).544
NIHSS at 48 hr14.5 (2–20)14 (2–20)15 (2–20).971
NIHSS at 7 days or discharge13 (2–30)13.5 (2–30)10 (1.5–25).657
24-Hour NIHSS improvement4 (0–11.5)3 (0–11)7 (2–14).308
Discharge NIHSS improvement9.5 (−2–16)7.5 (−9–15)12 (2.7–16.7).296
Mortality (%)2625.726.7.944
Hemorrhagic transformation (%)342750.089
Symptomatic hemorrhagic transformation (%)54.75.9.845
mRS at 3 months4 (0–6)3 (1–6)4 (0–6).980
mRS 0–2 at 3 months (%)40.54041.6.890
  • a Values are expressed as mean ± SD, median (IR), or percentage.